Literature DB >> 2956120

Lymphocyte subpopulations and function in cystic fibrosis.

M J Smith, L Morris, R J Stead, M E Hodson, J C Batten.   

Abstract

Circulating lymphocytes subpopulations and their function have been studied in 25 young adults with cystic fibrosis (CF) and 25 normal controls. Mean absolute numbers of all lymphocyte subsets in the CF group were not significantly different from the controls. Antibody-dependent cell cytotoxicity was significantly higher in the CF patients who had Pseudomonas aeruginosa in their sputum compared with those who had not and compared with the normal controls. Within the CF group the numbers of B cells, total T cells and OKT4+ helper cells fell as percent predicted peak expiratory flow (PEF) declined and similar significant positive correlations were found between lymphocyte subsets and percent predicted body weight. Serum albumin levels also showed a positive correlation with total T lymphocyte numbers (p less than 0.05). In vitro lymphocyte proliferative responses to mitogen were not significantly different from the control group, but again correlated positively with body weight in the CF patients. This provides further evidence that immune function in CF patients may become impaired as pulmonary disease and nutritional status deteriorate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2956120

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  4 in total

Review 1.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

2.  Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.

Authors:  G B Pier; S Takeda; M Grout; R B Markham
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

3.  Functional immunoregulatory T-cell abnormalities in cystic fibrosis patients.

Authors:  N Lahat; J Rivlin; T C Iancu
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

Review 4.  Comparing the effects of different cell death programs in tumor progression and immunotherapy.

Authors:  Michelle N Messmer; Annelise G Snyder; Andrew Oberst
Journal:  Cell Death Differ       Date:  2018-10-19       Impact factor: 15.828

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.